NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 64 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $155,000 | -27.2% | 163,942 | +2.2% | 0.00% | -100.0% |
| Q4 2015 | $213,000 | -36.8% | 160,482 | +8.5% | 0.00% | 0.0% |
| Q3 2015 | $337,000 | +47.8% | 147,957 | +4.3% | 0.00% | 0.0% |
| Q2 2015 | $228,000 | -5.0% | 141,801 | -6.3% | 0.00% | 0.0% |
| Q1 2015 | $240,000 | 0.0% | 151,256 | +19.2% | 0.00% | 0.0% |
| Q4 2014 | $240,000 | +50.9% | 126,856 | +5.6% | 0.00% | – |
| Q3 2014 | $159,000 | -10.7% | 120,081 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $178,000 | -9.2% | 120,081 | +13.3% | 0.00% | 0.0% |
| Q1 2014 | $196,000 | -15.2% | 106,031 | -5.0% | 0.00% | 0.0% |
| Q4 2013 | $231,000 | -23.5% | 111,621 | -2.1% | 0.00% | 0.0% |
| Q3 2013 | $302,000 | -1.3% | 114,021 | -0.6% | 0.00% | 0.0% |
| Q2 2013 | $306,000 | – | 114,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |